Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain
暂无分享,去创建一个
[1] M Komiyama,et al. MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. , 1987, AJNR. American journal of neuroradiology.
[2] R. Quisling,et al. Human brain infarcts: Gd-DTPA-enhanced MR imaging. , 1986, Radiology.
[3] V. Haughton,et al. A blinded clinical comparison of MR imaging and CT in neuroradiology. , 1986, Radiology.
[4] V. Haughton,et al. Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA. , 1986, Radiology.
[5] L D Lunsford,et al. Magnetic resonance imaging does not define tumor boundaries. , 1986, Acta radiologica. Supplementum.
[6] D. Thomas,et al. Contrast-enhanced MR imaging of malignant brain tumors. , 1985, AJNR. American journal of neuroradiology.
[7] C. Claussen,et al. Brain tumors: MR imaging with gadolinium-DTPA. , 1985, Radiology.
[8] R. Felix,et al. Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. , 1985, AJNR. American journal of neuroradiology.
[9] G. Bydder,et al. MR imaging of meningiomas including studies with and without gadolinium-DTPA. , 1985, Journal of computer assisted tomography.
[10] G M Bydder,et al. Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. , 1984, AJR. American journal of roentgenology.
[11] M Brant-Zawadzki,et al. Magnetic resonance of the brain: the optimal screening technique. , 1984, Radiology.
[12] G. Bydder,et al. INTRAVENOUS CHELATED GADOLINIUM AS A CONTRAST AGENT IN NMR IMAGING OF CEREBRAL TUMOURS , 1984, The Lancet.
[13] H. Weinmann,et al. First use of GdDTPA/dimeglumine in man. , 1984, Physiological chemistry and physics and medical NMR.
[14] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[15] G M Bydder,et al. Clinical NMR imaging of the brain: 140 cases. , 1982, AJR. American journal of roentgenology.